Advocacy
Advocacy
Advocacy
Advocacy is an essential part of SCAGO’s work as the organization continues to improve health outcomes and strengthen the voices of families impacted by sickle cell disease in the province.
Advocacy is an essential part of SCAGO’s work as the organization continues to improve health outcomes and strengthen the voices of families impacted by sickle cell disease in the province.
Advocacy Activities
Advocacy Activities
SCAGO holds action days and reception events at the Ontario legislature in order to raise awareness of the disease among the policymakers. Among other achievements, through our advocacy work, the Ontario Drug Program approved life-saving drugs for the treatment of iron overload for all with sickle cell disease regardless of their financial status.
SCAGO holds action days and reception events at the Ontario legislature in order to raise awareness of the disease among the policymakers. Among other achievements, through our advocacy work, the Ontario Drug Program approved life-saving drugs for the treatment of iron overload for all with sickle cell disease regardless of their financial status.
Exagamglogene Autotemcel (CASGEVY) Approved for Reimbursement in Canada for Sickle Cell and Thalassemia Diseases
Read the positive review by Canada's Drug Agency (CDA) on this groundbreaking gene therapy.
Exagamglogene Autotemcel (CASGEVY) Approved for Reimbursement in Canada for Sickle Cell and Thalassemia Diseases
Read the positive review by Canada's Drug Agency (CDA) on this groundbreaking gene therapy.
Bill 255
An Act to proclaim Sickle Cell Disease Awareness Day and Thalassemia Awareness Day
Bill 255
An Act to proclaim Sickle Cell Disease Awareness Day and Thalassemia Awareness Day
Sickle Cell Day Proclamations
June 19th 2023
Ontario Cities proclamations recognizing June 19th as World Sickle Cell Day.
Sickle Cell Day Proclamations
June 19th 2023
Ontario Cities proclamations recognizing June 19th as World Sickle Cell Day.
Exagamglogene Autotemcel (CASGEVY) Recommended for Reimbursement in Canada for Sickle Cell and Thalassemia Diseases
Read the positive review by Canada's Drug Agency (CDA) on this groundbreaking gene therapy.
Bill 255
June 03 2021
An Act to proclaim Sickle Cell Disease Awareness Day and Thalassemia Awareness Day
Exagamglogene Autotemcel (CASGEVY) Recommended for Reimbursement in Canada for Sickle Cell and Thalassemia Diseases
Read the positive review by Canada's Drug Agency (CDA) on this groundbreaking gene therapy.
Bill 255
June 03 2021
An Act to proclaim Sickle Cell Disease Awareness Day and Thalassemia Awareness Day
Explore More of
our Advocacy
Explore More of
our Advocacy
Quick Links
Location
Address: 235-415 Oakdale Rd. North York, ON M3N 1W7
Phone: GTA: 416-745-4267
Email: info@sicklecellanemia.ca
© SCAGO - All Rights Reserved -Disclaimer - Charitable Registration #: 83332 0872 RR 0001
Quick Links
Location
Address: 235-415 Oakdale Rd. North York, ON M3N 1W7
Phone: 416-745-4267
Email: info@sicklecellanemia.ca
© SCAGO - All Rights Reserved -Disclaimer - Charitable Registration #: 83332 0872 RR 0001
Quick Links
Location
Address: 235-415 Oakdale Rd.
North York, ON M3N 1W7
Phone: 416-745-4267
Email: info@sicklecellanemia.ca
© SCAGO - All Rights Reserved -Disclaimer - Charitable Registration #: 83332 0872 RR 0001